首页|期刊导航|中国整形与重建外科（英文）|PD-L1 Expression and Tumor Infiltrating Lymphocytes in Neurofibromatosis Type 1-Related Benign Tumors and Malignant Peripheral Nerve Sheath Tumors: An Implication for Immune Checkpoint Inhibition Therapy
PD-L1 Expression and Tumor Infiltrating Lymphocytes in Neurofibromatosis Type 1-Related Benign Tumors and Malignant Peripheral Nerve Sheath Tumors: An Implication for Immune Checkpoint Inhibition Therapy
Jin LIU Haibo LI Chengjiang WEI Qingfeng LI Zhichao WANG
中国整形与重建外科（英文）2021，Vol.3Issue(2)：63-67,75,6.
中国整形与重建外科（英文）2021，Vol.3Issue(2)：63-67,75,6.
PD-L1 Expression and Tumor Infiltrating Lymphocytes in Neurofibromatosis Type 1-Related Benign Tumors and Malignant Peripheral Nerve Sheath Tumors: An Implication for Immune Checkpoint Inhibition Therapy
PD-L1 Expression and Tumor Infiltrating Lymphocytes in Neurofibromatosis Type 1-Related Benign Tumors and Malignant Peripheral Nerve Sheath Tumors: An Implication for Immune Checkpoint Inhibition Therapy
摘要
关键词
Neurofibromatosis type 1/Malignant peripheral nerve sheath tumor/PD-L1/Tumor-infil-trating lymphocytes/Immune checkpoint inhibitionKey words
Neurofibromatosis type 1/Malignant peripheral nerve sheath tumor/PD-L1/Tumor-infil-trating lymphocytes/Immune checkpoint inhibition引用本文复制引用
Jin LIU,Haibo LI,Chengjiang WEI,Qingfeng LI,Zhichao WANG..PD-L1 Expression and Tumor Infiltrating Lymphocytes in Neurofibromatosis Type 1-Related Benign Tumors and Malignant Peripheral Nerve Sheath Tumors: An Implication for Immune Checkpoint Inhibition Therapy[J].中国整形与重建外科（英文）,2021,3(2):63-67,75,6.基金项目
This work was supported by the grants from the Youth Doctor Collaborative Innovation Team Project(QC201803)of Shanghai Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine,Shanghai Youth Top-Notch Talent Program(201809004),"Chenguang Program"supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commis-sion(19CG18)and Science and Technology Commission of Shanghai Municipality(19JC1413),Shanghai Rising Star Program(20QA1405600),Innovative research team of high-level local universities in Shanghai(SSMU-ZDCX20180700),and Shanghai Municipal Key Clinical Specialty(shslczdzk00901). （QC201803）
